| 1 | multicenter | 9,074 |
| 2 | multicentre | 3,200 |
| 3 | single-center | 1,404 |
| 4 | multi-center | 761 |
| 5 | multi-centre | 746 |
| 6 | multinational | 700 |
| 7 | multisite | 553 |
| 8 | single-centre | 455 |
| 9 | two-arm | 424 |
| 10 | single-arm | 314 |
| 11 | multicentric | 297 |
| 12 | multi-site | 267 |
| 13 | three-arm | 252 |
| 14 | two-group | 208 |
| 15 | multi-institutional | 189 |
| 16 | noncomparative | 157 |
| 17 | two-armed | 125 |
| 18 | 2-arm | 124 |
| 19 | 3-arm | 108 |
| 20 | non-interventional | 105 |
| 21 | multicentered | 98 |
| 22 | single-institution | 93 |
| 23 | monocentric | 87 |
| 24 | three-armed | 83 |
| 25 | 2-group | 69 |
| 26 | four-arm | 67 |
| 27 | two-center | 65 |
| 28 | phase-iii | 63 |
| 29 | three-group | 60 |
| 30 | two-centre | 46 |
| 31 | multi-centered | 45 |
| 32 | single-group | 40 |
| 33 | 2-part | 39 |
| 34 | 4-arm | 37 |
| 35 | multi-centred | 36 |
| 36 | stepped-wedge | 33 |
| 37 | multi-national | 32 |
| 38 | multi-country | 31 |
| 39 | non-blind | 30 |
| 40 | 3-group | 28 |
| 41 | one-group | 28 |
| 42 | multicentred | 26 |
| 43 | phase-3 | 24 |
| 44 | community-randomized | 23 |
| 45 | two-county | 23 |
| 46 | 3-armed | 22 |
| 47 | monocenter | 21 |
| 48 | multi-centric | 20 |
| 49 | multicountry | 20 |
| 50 | multiinstitutional | 18 |
| 51 | parallel-designed | 17 |
| 52 | 2-armed | 16 |
| 53 | comparative-effectiveness | 14 |
| 54 | unicenter | 14 |
| 55 | multiclinic | 13 |
| 56 | multiple-center | 13 |
| 57 | single-institutional | 13 |
| 58 | five-arm | 12 |
| 59 | four-site | 12 |
| 60 | single-centred | 11 |
| 61 | single-surgeon | 11 |
| 62 | community-randomised | 10 |
| 63 | four-armed | 10 |
| 64 | single-centered | 10 |
| 65 | dual-center | 9 |
| 66 | multi-institution | 9 |
| 67 | two-cohort | 9 |
| 68 | 4-center | 8 |
| 69 | cao/aro/aio-94 | 8 |
| 70 | 50-week | 7 |
| 71 | binational | 7 |
| 72 | four-center | 7 |
| 73 | geparquinto | 7 |
| 74 | multisurgeon | 7 |
| 75 | three-centre | 7 |
| 76 | five-center | 6 |
| 77 | fully-powered | 6 |
| 78 | mono-center | 6 |
| 79 | multipractice | 6 |
| 80 | one-center | 6 |
| 81 | semirandomized | 6 |
| 82 | six-center | 6 |
| 83 | verapamil-trandolapril | 6 |
| 84 | 3-center | 5 |
| 85 | 300-bed | 5 |
| 86 | dual-arm | 5 |
| 87 | lesser-quality | 5 |
| 88 | multihospital | 5 |
| 89 | reference-controlled | 5 |
| 90 | 5-arm | 4 |
| 91 | cvrct | 4 |
| 92 | d1-d3 | 4 |
| 93 | double-centre | 4 |
| 94 | european-australian | 4 |
| 95 | five-site | 4 |
| 96 | geparquattro | 4 |
| 97 | gp-based | 4 |
| 98 | group-randomised | 4 |
| 99 | low-powered | 4 |
| 100 | mono-centre | 4 |
| 101 | multicenters | 4 |
| 102 | post-test-only | 4 |
| 103 | ptcl-restricted | 4 |
| 104 | sample-sized | 4 |
| 105 | self-addressed | 4 |
| 106 | twenty-year | 4 |
| 107 | 2-centre | 3 |
| 108 | 2010-patient | 3 |
| 109 | 51-week | 3 |
| 110 | certican | 3 |
| 111 | equinox | 3 |
| 112 | grader-blinded | 3 |
| 113 | mono-centric | 3 |
| 114 | multicohort | 3 |
| 115 | no-profit | 3 |
| 116 | novus | 3 |
| 117 | seven-arm | 3 |
| 118 | seven-center | 3 |
| 119 | seven-site | 3 |
| 120 | singlecenter | 3 |
| 121 | thrilling | 3 |
| 122 | time-sequence | 3 |
| 123 | 1,300-patient | 2 |
| 124 | 20-community | 2 |
| 125 | 3558 | 2 |
| 126 | 40-fr | 2 |
| 127 | 48-participant | 2 |
| 128 | 600-patient | 2 |
| 129 | 82b | 2 |
| 130 | 82c | 2 |
| 131 | 9-center | 2 |
| 132 | achieve-1 | 2 |
| 133 | beggarticks | 2 |
| 134 | calorie-sufficient | 2 |
| 135 | co-published | 2 |
| 136 | cohort-nested | 2 |
| 137 | community-planned | 2 |
| 138 | cyp2c9/10 | 2 |
| 139 | daily-level | 2 |
| 140 | descriptive-analytical | 2 |
| 141 | double-mask | 2 |
| 142 | ectaz | 2 |
| 143 | factorial-designed | 2 |
| 144 | household-cluster | 2 |
| 145 | identically-designed | 2 |
| 146 | kopac | 2 |
| 147 | limited-scope | 2 |
| 148 | locally-tailored | 2 |
| 149 | magrit | 2 |
| 150 | mhf-diet | 2 |
| 151 | microtechnology | 2 |
| 152 | multicampus | 2 |
| 153 | multiple-project | 2 |
| 154 | non-double-blind | 2 |
| 155 | non-ivf | 2 |
| 156 | non-thienopyridine | 2 |
| 157 | one-pill | 2 |
| 158 | phase-iiib | 2 |
| 159 | phosphatonin | 2 |
| 160 | pore-sized | 2 |
| 161 | post-only | 2 |
| 162 | replicate-use | 2 |
| 163 | resident-led | 2 |
| 164 | semi-isolated | 2 |
| 165 | semiblinded | 2 |
| 166 | sharp-pointed | 2 |
| 167 | single-assessor | 2 |
| 168 | six-armed | 2 |
| 169 | staggered-entry | 2 |
| 170 | statine | 2 |
| 171 | surgeon-blinded | 2 |
| 172 | te23 | 2 |
| 173 | trackball | 2 |
| 174 | triazolobenzodiazepine | 2 |
| 175 | trihexose | 2 |
| 176 | triventricular | 2 |
| 177 | two-arms | 2 |
| 178 | verapamil-sr/trandolapril | 2 |
| 179 | ,were | 1 |
| 180 | 0.75-ma | 1 |
| 181 | 0.9-ma | 1 |
| 182 | 1,300-bed | 1 |
| 183 | 1,5-benzodiazepine | 1 |
| 184 | 1.7-cm | 1 |
| 185 | 10-16-week | 1 |
| 186 | 104:12518-12523 | 1 |
| 187 | 11-nprs | 1 |
| 188 | 12-class | 1 |
| 189 | 15,760 | 1 |
| 190 | 15-lap | 1 |
| 191 | 1551-g | 1 |
| 192 | 16-24-week | 1 |
| 193 | 17-question | 1 |
| 194 | 19-center | 1 |
| 195 | 2,010-patient | 1 |
| 196 | 2-aminoazine | 1 |
| 197 | 2-benzyloxy- | 1 |
| 198 | 2-oxoaldehyde | 1 |
| 199 | 2-weeks-on | 1 |
| 200 | 2000-patient | 1 |
| 201 | 22-community | 1 |
| 202 | 25-institution | 1 |
| 203 | 29-month-period | 1 |
| 204 | 3-nitro- | 1 |
| 205 | 3-parallel-arm | 1 |
| 206 | 3-phased | 1 |
| 207 | 3.4-yr | 1 |
| 208 | 3000-patient | 1 |
| 209 | 31-bed | 1 |
| 210 | 31-patient | 1 |
| 211 | 3300-participant | 1 |
| 212 | 34-residue | 1 |
| 213 | 36-antenna | 1 |
| 214 | 383-d | 1 |
| 215 | 39-center | 1 |
| 216 | 390-bed | 1 |
| 217 | 4'-hydroxy-3-methoxyflavone | 1 |
| 218 | 4-lesson | 1 |
| 219 | 4-wave | 1 |
| 220 | 4-year-period | 1 |
| 221 | 4.25-year | 1 |
| 222 | 4000-patient | 1 |
| 223 | 42-night | 1 |
| 224 | 42.5-kda | 1 |
| 225 | 5-w | 1 |
| 226 | 5.0ml | 1 |
| 227 | 50j | 1 |
| 228 | 510k-approved | 1 |
| 229 | 6,711 | 1 |
| 230 | 6-12-week | 1 |
| 231 | 6-arm | 1 |
| 232 | 60-ma | 1 |
| 233 | 61-item | 1 |
| 234 | 7,447-participant | 1 |
| 235 | 7-center | 1 |
| 236 | 700-patient | 1 |
| 237 | 7000-patient | 1 |
| 238 | 75-base | 1 |
| 239 | 76-item | 1 |
| 240 | 78-day | 1 |
| 241 | 79-patient | 1 |
| 242 | 9-trial | 1 |
| 243 | 90-patient | 1 |
| 244 | 915-mhz | 1 |
| 245 | 95,299-bp-long | 1 |
| 246 | arteries-iv | 1 |
| 247 | association-9802 | 1 |
| 248 | australia.design | 1 |
| 249 | babygirl | 1 |
| 250 | balaclava | 1 |
| 251 | barriada | 1 |
| 252 | bayesian-framework | 1 |
| 253 | bee-derived | 1 |
| 254 | behaviorally-centered | 1 |
| 255 | bi-gene | 1 |
| 256 | bio-inactive | 1 |
| 257 | boggy | 1 |
| 258 | bookmark | 1 |
| 259 | booster-dose | 1 |
| 260 | botiquín | 1 |
| 261 | breathtron® | 1 |
| 262 | busybody | 1 |
| 263 | c-counter | 1 |
| 264 | c-free | 1 |
| 265 | c-galloylglycoside | 1 |
| 266 | c.584dela | 1 |
| 267 | calorie-reduced | 1 |
| 268 | cao-aro | 1 |
| 269 | carbohydrate-coated | 1 |
| 270 | caregiver-youth | 1 |
| 271 | carotenoid-controlled | 1 |
| 272 | cbt-naive | 1 |
| 273 | cd4-related | 1 |
| 274 | cdc-designated | 1 |
| 275 | chemically-activated | 1 |
| 276 | chloride-reduced | 1 |
| 277 | chondrodystrophy | 1 |
| 278 | chore/burden | 1 |
| 279 | cicatrizant | 1 |
| 280 | cilinical | 1 |
| 281 | cis-c | 1 |
| 282 | clarificant | 1 |
| 283 | clear-ivh | 1 |
| 284 | clinic-modelling | 1 |
| 285 | co-sensitizer | 1 |
| 286 | codicil | 1 |
| 287 | cofactor-based-inhibitor | 1 |
| 288 | cognin | 1 |
| 289 | community-integrated | 1 |
| 290 | comparative-group | 1 |
| 291 | conceptually-based | 1 |
| 292 | copa-airline | 1 |
| 293 | coping-technique | 1 |
| 294 | copper-sulfate-filled | 1 |
| 295 | cormet | 1 |
| 296 | corymb | 1 |
| 297 | counterproof | 1 |
| 298 | county-owned | 1 |
| 299 | cpo-based | 1 |
| 300 | crca | 1 |
| 301 | cut-and-carry | 1 |
| 302 | cycling-to-exhaustion | 1 |
| 303 | cyclooxygenase-inhibitor | 1 |
| 304 | cyclopentyltriazolopyrimidine | 1 |
| 305 | d2/d3-antagonist | 1 |
| 306 | danish-austrian | 1 |
| 307 | deep-reaching | 1 |
| 308 | defensive-like | 1 |
| 309 | defucosylated | 1 |
| 310 | dental-directed | 1 |
| 311 | denunciation | 1 |
| 312 | descriptive-analysis | 1 |
| 313 | dhhs-funded | 1 |
| 314 | dichotomousoutcome | 1 |
| 315 | dictionary-based | 1 |
| 316 | dielectrophile | 1 |
| 317 | difference.one | 1 |
| 318 | dimethylbiguanide | 1 |
| 319 | dinucleophile | 1 |
| 320 | diphenylbutylpiperidine | 1 |
| 321 | dissonance-enhancing | 1 |
| 322 | district-based | 1 |
| 323 | disulfide-deficient | 1 |
| 324 | dolderbar | 1 |
| 325 | dose-block-randomized | 1 |
| 326 | dose-searching | 1 |
| 327 | dose/duration-ranging | 1 |
| 328 | double-control | 1 |
| 329 | double-phased | 1 |
| 330 | double/blind | 1 |
| 331 | dutpase-like | 1 |
| 332 | dysnatraemia | 1 |
| 333 | fast-learning | 1 |
| 334 | fast-mapping | 1 |
| 335 | febuxostat/allopurinol | 1 |
| 336 | fiancée | 1 |
| 337 | firefighter-delivered | 1 |
| 338 | first-in-disease | 1 |
| 339 | five-centre | 1 |
| 340 | five-contact | 1 |
| 341 | five-subject | 1 |
| 342 | flavone-rich | 1 |
| 343 | flexstation | 1 |
| 344 | flower-specific | 1 |
| 345 | fluoro-chinolone | 1 |
| 346 | forsch | 1 |
| 347 | four-parallel-arm | 1 |
| 348 | four-trial | 1 |
| 349 | fourcenter | 1 |
| 350 | framework/theory | 1 |
| 351 | g-csf- | 1 |
| 352 | galactosyl-α | 1 |
| 353 | gamma-counter | 1 |
| 354 | gauguin | 1 |
| 355 | gene-of-interest | 1 |
| 356 | geneticist/oncologist | 1 |
| 357 | glutathione-independent | 1 |
| 358 | gold-shaded | 1 |
| 359 | goldilocks | 1 |
| 360 | gondwanatherian | 1 |
| 361 | growing-rod | 1 |
| 362 | haemocoel | 1 |
| 363 | half-solid | 1 |
| 364 | haloperidol-referenced | 1 |
| 365 | hawaiian-based | 1 |
| 366 | he65-like | 1 |
| 367 | head-mounted-display | 1 |
| 368 | health-literacy-sensitive | 1 |
| 369 | helmet-type | 1 |
| 370 | heparin-sensitive | 1 |
| 371 | hf-nurse | 1 |
| 372 | high-complex-carbohydrate | 1 |
| 373 | high-retention | 1 |
| 374 | high-risk-population | 1 |
| 375 | high-sense-of-control | 1 |
| 376 | high-wnt | 1 |
| 377 | hilbert-transform | 1 |
| 378 | hispanic-specific | 1 |
| 379 | hmg-coa-reductase-inhibitor | 1 |
| 380 | hodos | 1 |
| 381 | hr=1.14 | 1 |
| 382 | hummock | 1 |
| 383 | hunch | 1 |
| 384 | hyper-reflexive | 1 |
| 385 | hyperflexible | 1 |
| 386 | hypermigratory | 1 |
| 387 | intra-lock | 1 |
| 388 | jew | 1 |
| 389 | k-space-segmented | 1 |
| 390 | ketoaldehyde | 1 |
| 391 | lactose-negative | 1 |
| 392 | lard-based | 1 |
| 393 | large-gauge | 1 |
| 394 | large-numbered | 1 |
| 395 | later-acting | 1 |
| 396 | less-distinct | 1 |
| 397 | light-pecking | 1 |
| 398 | light-porous-particle | 1 |
| 399 | lighthearted | 1 |
| 400 | lipex-403 | 1 |
| 401 | llama-derived | 1 |
| 402 | logistic-regression-model | 1 |
| 403 | longport | 1 |
| 404 | low-impulsivity | 1 |
| 405 | low-phase | 1 |
| 406 | low-resource-demand | 1 |
| 407 | lym-3001 | 1 |
| 408 | m-inflated | 1 |
| 409 | maasol | 1 |
| 410 | magnesium-mediated | 1 |
| 411 | male-focused | 1 |
| 412 | mannose-rich | 1 |
| 413 | margit | 1 |
| 414 | matrixed | 1 |
| 415 | meatourethroscope | 1 |
| 416 | medication-withdrawal | 1 |
| 417 | medium-temperature | 1 |
| 418 | mek-inhibitor-sensitive | 1 |
| 419 | melibiose-negative | 1 |
| 420 | metallo-ß-lactamase | 1 |
| 421 | microbrewery | 1 |
| 422 | midewanniquay | 1 |
| 423 | mir-371 | 1 |
| 424 | mirtron | 1 |
| 425 | mmc/5-fu | 1 |
| 426 | monarchy | 1 |
| 427 | monomodality | 1 |
| 428 | month/bimonthly | 1 |
| 429 | multi-behavioral | 1 |
| 430 | multi-centre-randomised-trial | 1 |
| 431 | multi-intention | 1 |
| 432 | multi-interval | 1 |
| 433 | multi-night | 1 |
| 434 | multi-replicon | 1 |
| 435 | multicenter-cooperative | 1 |
| 436 | multicenter-randomized | 1 |
| 437 | multiphased | 1 |
| 438 | multiple-blind | 1 |
| 439 | multiprovince | 1 |
| 440 | myopia-control | 1 |
| 441 | naphthalene-derivative | 1 |
| 442 | nephrostomy-tube | 1 |
| 443 | net-cage | 1 |
| 444 | neurolinguist | 1 |
| 445 | nida-funded | 1 |
| 446 | nine-center | 1 |
| 447 | no-mix | 1 |
| 448 | non-amphetamine | 1 |
| 449 | non-betablocker | 1 |
| 450 | non-calorie-restricted | 1 |
| 451 | non-detachable | 1 |
| 452 | non-detubularised | 1 |
| 453 | non-isotropic | 1 |
| 454 | non-plasma-derived | 1 |
| 455 | non-protein-forming | 1 |
| 456 | non-rattlesnake | 1 |
| 457 | non-sequitur | 1 |
| 458 | noncentralized | 1 |
| 459 | noncollaborative | 1 |
| 460 | nonechocardiographer | 1 |
| 461 | noninferiority-designed | 1 |
| 462 | nonpelleted | 1 |
| 463 | nonphosphate | 1 |
| 464 | nonrandomized/partly | 1 |
| 465 | nonrestricted | 1 |
| 466 | north-to-south | 1 |
| 467 | nos-independent | 1 |
| 468 | nurse-presented | 1 |
| 469 | older-specific | 1 |
| 470 | orthopterans | 1 |
| 471 | p110δinhibitor | 1 |
| 472 | pan-world | 1 |
| 473 | parallel-group-design | 1 |
| 474 | participation-oriented | 1 |
| 475 | patient-selective | 1 |
| 476 | patient/employee/employer/physician | 1 |
| 477 | peridischarge | 1 |
| 478 | pharyngolaryngobronchitis | 1 |
| 479 | phosphatase-resistant | 1 |
| 480 | phosphatidylethnolamine | 1 |
| 481 | phosphatidylgylycerol | 1 |
| 482 | photo-novel | 1 |
| 483 | phthalocyanine-derivative | 1 |
| 484 | physician-blind | 1 |
| 485 | physician-sponsored | 1 |
| 486 | picture-analyzer | 1 |
| 487 | pidgley | 1 |
| 488 | placed-controlled | 1 |
| 489 | platelet-stimulating | 1 |
| 490 | plum-sized | 1 |
| 491 | polymercaptosiloxane | 1 |
| 492 | post-2005 | 1 |
| 493 | pqdt | 1 |
| 494 | pre-post-design | 1 |
| 495 | pre-switched | 1 |
| 496 | preevaluation | 1 |
| 497 | preperitioneal | 1 |
| 498 | pride- | 1 |
| 499 | progenitor-like | 1 |
| 500 | proteome-scale | 1 |
| 501 | proto-typical | 1 |
| 502 | pseudo-residual | 1 |
| 503 | pyranoquinolone | 1 |
| 504 | q318x | 1 |
| 505 | quasy-experimental | 1 |
| 506 | raisin- | 1 |
| 507 | random-coefficient-dependent | 1 |
| 508 | randomized-controlled-treatment | 1 |
| 509 | rectally-applied | 1 |
| 510 | relapsed-aml2001/01 | 1 |
| 511 | researcher-initiated | 1 |
| 512 | retrieval-phase | 1 |
| 513 | rickettsia-like | 1 |
| 514 | rotodynamic | 1 |
| 515 | round-bottomed | 1 |
| 516 | sam-riboswitch | 1 |
| 517 | science.finally | 1 |
| 518 | self-inducible | 1 |
| 519 | semi-woody | 1 |
| 520 | semielevated | 1 |
| 521 | seroprophylaxis | 1 |
| 522 | seventeen-centre | 1 |
| 523 | sewer/gutter | 1 |
| 524 | shifts-randomized | 1 |
| 525 | sibling-split | 1 |
| 526 | simple-blinded | 1 |
| 527 | simple-in-design | 1 |
| 528 | simple-operating | 1 |
| 529 | single-antibiotic | 1 |
| 530 | single-bind | 1 |
| 531 | single-headed-toothbrush | 1 |
| 532 | single-macronutrient | 1 |
| 533 | single-reviewer | 1 |
| 534 | single-tiered | 1 |
| 535 | single-turn | 1 |
| 536 | single/multicenter | 1 |
| 537 | sittingposition | 1 |
| 538 | six-sites | 1 |
| 539 | six-week-treatment | 1 |
| 540 | soap-opera-themed | 1 |
| 541 | solemn | 1 |
| 542 | sound-proofed | 1 |
| 543 | soy-protein-isolate | 1 |
| 544 | sp6likevirus | 1 |
| 545 | specialist-administered | 1 |
| 546 | sperm-interacting | 1 |
| 547 | staged-based | 1 |
| 548 | strain-unspecific | 1 |
| 549 | strawberry- | 1 |
| 550 | study-case-control | 1 |
| 551 | subcutaneous-mucosa | 1 |
| 552 | sulphonlyurea | 1 |
| 553 | superblade | 1 |
| 554 | surgeon-masked | 1 |
| 555 | task-battery | 1 |
| 556 | teammate | 1 |
| 557 | temporally-correct | 1 |
| 558 | temporary-type | 1 |
| 559 | ten-variable | 1 |
| 560 | tensipresser | 1 |
| 561 | test-age-equivalent | 1 |
| 562 | test-chart | 1 |
| 563 | tetrahexose | 1 |
| 564 | tetrahydrobenzocyclononenone | 1 |
| 565 | th1-pathway | 1 |
| 566 | then-standard | 1 |
| 567 | theoretically-defensible | 1 |
| 568 | theoreticallydriven | 1 |
| 569 | three-attack | 1 |
| 570 | three-plus-three | 1 |
| 571 | time-clustered | 1 |
| 572 | titration-protocol | 1 |
| 573 | tnfr1/jnk1/2 | 1 |
| 574 | toluene-resistant | 1 |
| 575 | training-independent | 1 |
| 576 | trans-national | 1 |
| 577 | treatment-derived | 1 |
| 578 | trial.obviously | 1 |
| 579 | triple-injection | 1 |
| 580 | trpv1-antagonist | 1 |
| 581 | tunnel-ventilated | 1 |
| 582 | twin-center | 1 |
| 583 | two-centred | 1 |
| 584 | two-chambered | 1 |
| 585 | two-diet | 1 |
| 586 | two-pole | 1 |
| 587 | two-treatment-arms | 1 |
| 588 | uichronic | 1 |
| 589 | ultrasonographic-screening | 1 |
| 590 | undoable | 1 |
| 591 | universal-coverage | 1 |
| 592 | university-affiliate | 1 |
| 593 | user-driven | 1 |
| 594 | vaccine-probe-study | 1 |
| 595 | varicocoele | 1 |
| 596 | viking | 1 |
| 597 | visually-identical | 1 |
| 598 | vulnery | 1 |
| 599 | wearisome | 1 |
| 600 | well-corticated | 1 |
| 601 | well-randomized | 1 |
| 602 | westerner | 1 |
| 603 | westlaw | 1 |
| 604 | wide-reach | 1 |
| 605 | widespread-growing | 1 |
| 606 | windbreak | 1 |
| 607 | within-nested | 1 |
| 608 | within-organizations | 1 |
| 609 | within-subject-design | 1 |
| 610 | woman.usually | 1 |
| 611 | yoghurt- | 1 |
| 612 | zinc-metalloendopeptidase | 1 |
| 613 | ø5-mm | 1 |
| 614 | κ³-manner | 1 |
| 615 | μ3-hydride | 1 |
| 616 | €590±43 | 1 |
| 617 | ≤68-week | 1 |
| 1 | ,were | 1 |
| 2 | 0.75-ma | 1 |
| 3 | 0.9-ma | 1 |
| 4 | 1,300-bed | 1 |
| 5 | 1,300-patient | 2 |
| 6 | 1,5-benzodiazepine | 1 |
| 7 | 1.7-cm | 1 |
| 8 | 10-16-week | 1 |
| 9 | 104:12518-12523 | 1 |
| 10 | 11-nprs | 1 |
| 11 | 12-class | 1 |
| 12 | 15,760 | 1 |
| 13 | 15-lap | 1 |
| 14 | 1551-g | 1 |
| 15 | 16-24-week | 1 |
| 16 | 17-question | 1 |
| 17 | 19-center | 1 |
| 18 | 2,010-patient | 1 |
| 19 | 2-aminoazine | 1 |
| 20 | 2-arm | 124 |
| 21 | 2-armed | 16 |
| 22 | 2-benzyloxy- | 1 |
| 23 | 2-centre | 3 |
| 24 | 2-group | 69 |
| 25 | 2-oxoaldehyde | 1 |
| 26 | 2-part | 39 |
| 27 | 2-weeks-on | 1 |
| 28 | 20-community | 2 |
| 29 | 2000-patient | 1 |
| 30 | 2010-patient | 3 |
| 31 | 22-community | 1 |
| 32 | 25-institution | 1 |
| 33 | 29-month-period | 1 |
| 34 | 3-arm | 108 |
| 35 | 3-armed | 22 |
| 36 | 3-center | 5 |
| 37 | 3-group | 28 |
| 38 | 3-nitro- | 1 |
| 39 | 3-parallel-arm | 1 |
| 40 | 3-phased | 1 |
| 41 | 3.4-yr | 1 |
| 42 | 300-bed | 5 |
| 43 | 3000-patient | 1 |
| 44 | 31-bed | 1 |
| 45 | 31-patient | 1 |
| 46 | 3300-participant | 1 |
| 47 | 34-residue | 1 |
| 48 | 3558 | 2 |
| 49 | 36-antenna | 1 |
| 50 | 383-d | 1 |
| 51 | 39-center | 1 |
| 52 | 390-bed | 1 |
| 53 | 4'-hydroxy-3-methoxyflavone | 1 |
| 54 | 4-arm | 37 |
| 55 | 4-center | 8 |
| 56 | 4-lesson | 1 |
| 57 | 4-wave | 1 |
| 58 | 4-year-period | 1 |
| 59 | 4.25-year | 1 |
| 60 | 40-fr | 2 |
| 61 | 4000-patient | 1 |
| 62 | 42-night | 1 |
| 63 | 42.5-kda | 1 |
| 64 | 48-participant | 2 |
| 65 | 5-arm | 4 |
| 66 | 5-w | 1 |
| 67 | 5.0ml | 1 |
| 68 | 50-week | 7 |
| 69 | 50j | 1 |
| 70 | 51-week | 3 |
| 71 | 510k-approved | 1 |
| 72 | 6,711 | 1 |
| 73 | 6-12-week | 1 |
| 74 | 6-arm | 1 |
| 75 | 60-ma | 1 |
| 76 | 600-patient | 2 |
| 77 | 61-item | 1 |
| 78 | 7,447-participant | 1 |
| 79 | 7-center | 1 |
| 80 | 700-patient | 1 |
| 81 | 7000-patient | 1 |
| 82 | 75-base | 1 |
| 83 | 76-item | 1 |
| 84 | 78-day | 1 |
| 85 | 79-patient | 1 |
| 86 | 82b | 2 |
| 87 | 82c | 2 |
| 88 | 9-center | 2 |
| 89 | 9-trial | 1 |
| 90 | 90-patient | 1 |
| 91 | 915-mhz | 1 |
| 92 | 95,299-bp-long | 1 |
| 93 | achieve-1 | 2 |
| 94 | arteries-iv | 1 |
| 95 | association-9802 | 1 |
| 96 | australia.design | 1 |
| 97 | babygirl | 1 |
| 98 | balaclava | 1 |
| 99 | barriada | 1 |
| 100 | bayesian-framework | 1 |
| 101 | bee-derived | 1 |
| 102 | beggarticks | 2 |
| 103 | behaviorally-centered | 1 |
| 104 | bi-gene | 1 |
| 105 | binational | 7 |
| 106 | bio-inactive | 1 |
| 107 | boggy | 1 |
| 108 | bookmark | 1 |
| 109 | booster-dose | 1 |
| 110 | botiquín | 1 |
| 111 | breathtron® | 1 |
| 112 | busybody | 1 |
| 113 | c-counter | 1 |
| 114 | c-free | 1 |
| 115 | c-galloylglycoside | 1 |
| 116 | c.584dela | 1 |
| 117 | calorie-reduced | 1 |
| 118 | calorie-sufficient | 2 |
| 119 | cao-aro | 1 |
| 120 | cao/aro/aio-94 | 8 |
| 121 | carbohydrate-coated | 1 |
| 122 | caregiver-youth | 1 |
| 123 | carotenoid-controlled | 1 |
| 124 | cbt-naive | 1 |
| 125 | cd4-related | 1 |
| 126 | cdc-designated | 1 |
| 127 | certican | 3 |
| 128 | chemically-activated | 1 |
| 129 | chloride-reduced | 1 |
| 130 | chondrodystrophy | 1 |
| 131 | chore/burden | 1 |
| 132 | cicatrizant | 1 |
| 133 | cilinical | 1 |
| 134 | cis-c | 1 |
| 135 | clarificant | 1 |
| 136 | clear-ivh | 1 |
| 137 | clinic-modelling | 1 |
| 138 | co-published | 2 |
| 139 | co-sensitizer | 1 |
| 140 | codicil | 1 |
| 141 | cofactor-based-inhibitor | 1 |
| 142 | cognin | 1 |
| 143 | cohort-nested | 2 |
| 144 | community-integrated | 1 |
| 145 | community-planned | 2 |
| 146 | community-randomised | 10 |
| 147 | community-randomized | 23 |
| 148 | comparative-effectiveness | 14 |
| 149 | comparative-group | 1 |
| 150 | conceptually-based | 1 |
| 151 | copa-airline | 1 |
| 152 | coping-technique | 1 |
| 153 | copper-sulfate-filled | 1 |
| 154 | cormet | 1 |
| 155 | corymb | 1 |
| 156 | counterproof | 1 |
| 157 | county-owned | 1 |
| 158 | cpo-based | 1 |
| 159 | crca | 1 |
| 160 | cut-and-carry | 1 |
| 161 | cvrct | 4 |
| 162 | cycling-to-exhaustion | 1 |
| 163 | cyclooxygenase-inhibitor | 1 |
| 164 | cyclopentyltriazolopyrimidine | 1 |
| 165 | cyp2c9/10 | 2 |
| 166 | d1-d3 | 4 |
| 167 | d2/d3-antagonist | 1 |
| 168 | daily-level | 2 |
| 169 | danish-austrian | 1 |
| 170 | deep-reaching | 1 |
| 171 | defensive-like | 1 |
| 172 | defucosylated | 1 |
| 173 | dental-directed | 1 |
| 174 | denunciation | 1 |
| 175 | descriptive-analysis | 1 |
| 176 | descriptive-analytical | 2 |
| 177 | dhhs-funded | 1 |
| 178 | dichotomousoutcome | 1 |
| 179 | dictionary-based | 1 |
| 180 | dielectrophile | 1 |
| 181 | difference.one | 1 |
| 182 | dimethylbiguanide | 1 |
| 183 | dinucleophile | 1 |
| 184 | diphenylbutylpiperidine | 1 |
| 185 | dissonance-enhancing | 1 |
| 186 | district-based | 1 |
| 187 | disulfide-deficient | 1 |
| 188 | dolderbar | 1 |
| 189 | dose-block-randomized | 1 |
| 190 | dose-searching | 1 |
| 191 | dose/duration-ranging | 1 |
| 192 | double-centre | 4 |
| 193 | double-control | 1 |
| 194 | double-mask | 2 |
| 195 | double-phased | 1 |
| 196 | double/blind | 1 |
| 197 | dual-arm | 5 |
| 198 | dual-center | 9 |
| 199 | dutpase-like | 1 |
| 200 | dysnatraemia | 1 |
| 201 | ectaz | 2 |
| 202 | equinox | 3 |
| 203 | european-australian | 4 |
| 204 | factorial-designed | 2 |
| 205 | fast-learning | 1 |
| 206 | fast-mapping | 1 |
| 207 | febuxostat/allopurinol | 1 |
| 208 | fiancée | 1 |
| 209 | firefighter-delivered | 1 |
| 210 | first-in-disease | 1 |
| 211 | five-arm | 12 |
| 212 | five-center | 6 |
| 213 | five-centre | 1 |
| 214 | five-contact | 1 |
| 215 | five-site | 4 |
| 216 | five-subject | 1 |
| 217 | flavone-rich | 1 |
| 218 | flexstation | 1 |
| 219 | flower-specific | 1 |
| 220 | fluoro-chinolone | 1 |
| 221 | forsch | 1 |
| 222 | four-arm | 67 |
| 223 | four-armed | 10 |
| 224 | four-center | 7 |
| 225 | four-parallel-arm | 1 |
| 226 | four-site | 12 |
| 227 | four-trial | 1 |
| 228 | fourcenter | 1 |
| 229 | framework/theory | 1 |
| 230 | fully-powered | 6 |
| 231 | g-csf- | 1 |
| 232 | galactosyl-α | 1 |
| 233 | gamma-counter | 1 |
| 234 | gauguin | 1 |
| 235 | gene-of-interest | 1 |
| 236 | geneticist/oncologist | 1 |
| 237 | geparquattro | 4 |
| 238 | geparquinto | 7 |
| 239 | glutathione-independent | 1 |
| 240 | gold-shaded | 1 |
| 241 | goldilocks | 1 |
| 242 | gondwanatherian | 1 |
| 243 | gp-based | 4 |
| 244 | grader-blinded | 3 |
| 245 | group-randomised | 4 |
| 246 | growing-rod | 1 |
| 247 | haemocoel | 1 |
| 248 | half-solid | 1 |
| 249 | haloperidol-referenced | 1 |
| 250 | hawaiian-based | 1 |
| 251 | he65-like | 1 |
| 252 | head-mounted-display | 1 |
| 253 | health-literacy-sensitive | 1 |
| 254 | helmet-type | 1 |
| 255 | heparin-sensitive | 1 |
| 256 | hf-nurse | 1 |
| 257 | high-complex-carbohydrate | 1 |
| 258 | high-retention | 1 |
| 259 | high-risk-population | 1 |
| 260 | high-sense-of-control | 1 |
| 261 | high-wnt | 1 |
| 262 | hilbert-transform | 1 |
| 263 | hispanic-specific | 1 |
| 264 | hmg-coa-reductase-inhibitor | 1 |
| 265 | hodos | 1 |
| 266 | household-cluster | 2 |
| 267 | hr=1.14 | 1 |
| 268 | hummock | 1 |
| 269 | hunch | 1 |
| 270 | hyper-reflexive | 1 |
| 271 | hyperflexible | 1 |
| 272 | hypermigratory | 1 |
| 273 | identically-designed | 2 |
| 274 | intra-lock | 1 |
| 275 | jew | 1 |
| 276 | k-space-segmented | 1 |
| 277 | ketoaldehyde | 1 |
| 278 | kopac | 2 |
| 279 | lactose-negative | 1 |
| 280 | lard-based | 1 |
| 281 | large-gauge | 1 |
| 282 | large-numbered | 1 |
| 283 | later-acting | 1 |
| 284 | less-distinct | 1 |
| 285 | lesser-quality | 5 |
| 286 | light-pecking | 1 |
| 287 | light-porous-particle | 1 |
| 288 | lighthearted | 1 |
| 289 | limited-scope | 2 |
| 290 | lipex-403 | 1 |
| 291 | llama-derived | 1 |
| 292 | locally-tailored | 2 |
| 293 | logistic-regression-model | 1 |
| 294 | longport | 1 |
| 295 | low-impulsivity | 1 |
| 296 | low-phase | 1 |
| 297 | low-powered | 4 |
| 298 | low-resource-demand | 1 |
| 299 | lym-3001 | 1 |
| 300 | m-inflated | 1 |
| 301 | maasol | 1 |
| 302 | magnesium-mediated | 1 |
| 303 | magrit | 2 |
| 304 | male-focused | 1 |
| 305 | mannose-rich | 1 |
| 306 | margit | 1 |
| 307 | matrixed | 1 |
| 308 | meatourethroscope | 1 |
| 309 | medication-withdrawal | 1 |
| 310 | medium-temperature | 1 |
| 311 | mek-inhibitor-sensitive | 1 |
| 312 | melibiose-negative | 1 |
| 313 | metallo-ß-lactamase | 1 |
| 314 | mhf-diet | 2 |
| 315 | microbrewery | 1 |
| 316 | microtechnology | 2 |
| 317 | midewanniquay | 1 |
| 318 | mir-371 | 1 |
| 319 | mirtron | 1 |
| 320 | mmc/5-fu | 1 |
| 321 | monarchy | 1 |
| 322 | mono-center | 6 |
| 323 | mono-centre | 4 |
| 324 | mono-centric | 3 |
| 325 | monocenter | 21 |
| 326 | monocentric | 87 |
| 327 | monomodality | 1 |
| 328 | month/bimonthly | 1 |
| 329 | multi-behavioral | 1 |
| 330 | multi-center | 761 |
| 331 | multi-centered | 45 |
| 332 | multi-centre | 746 |
| 333 | multi-centre-randomised-trial | 1 |
| 334 | multi-centred | 36 |
| 335 | multi-centric | 20 |
| 336 | multi-country | 31 |
| 337 | multi-institution | 9 |
| 338 | multi-institutional | 189 |
| 339 | multi-intention | 1 |
| 340 | multi-interval | 1 |
| 341 | multi-national | 32 |
| 342 | multi-night | 1 |
| 343 | multi-replicon | 1 |
| 344 | multi-site | 267 |
| 345 | multicampus | 2 |
| 346 | multicenter | 9,074 |
| 347 | multicenter-cooperative | 1 |
| 348 | multicenter-randomized | 1 |
| 349 | multicentered | 98 |
| 350 | multicenters | 4 |
| 351 | multicentre | 3,200 |
| 352 | multicentred | 26 |
| 353 | multicentric | 297 |
| 354 | multiclinic | 13 |
| 355 | multicohort | 3 |
| 356 | multicountry | 20 |
| 357 | multihospital | 5 |
| 358 | multiinstitutional | 18 |
| 359 | multinational | 700 |
| 360 | multiphased | 1 |
| 361 | multiple-blind | 1 |
| 362 | multiple-center | 13 |
| 363 | multiple-project | 2 |
| 364 | multipractice | 6 |
| 365 | multiprovince | 1 |
| 366 | multisite | 553 |
| 367 | multisurgeon | 7 |
| 368 | myopia-control | 1 |
| 369 | naphthalene-derivative | 1 |
| 370 | nephrostomy-tube | 1 |
| 371 | net-cage | 1 |
| 372 | neurolinguist | 1 |
| 373 | nida-funded | 1 |
| 374 | nine-center | 1 |
| 375 | no-mix | 1 |
| 376 | no-profit | 3 |
| 377 | non-amphetamine | 1 |
| 378 | non-betablocker | 1 |
| 379 | non-blind | 30 |
| 380 | non-calorie-restricted | 1 |
| 381 | non-detachable | 1 |
| 382 | non-detubularised | 1 |
| 383 | non-double-blind | 2 |
| 384 | non-interventional | 105 |
| 385 | non-isotropic | 1 |
| 386 | non-ivf | 2 |
| 387 | non-plasma-derived | 1 |
| 388 | non-protein-forming | 1 |
| 389 | non-rattlesnake | 1 |
| 390 | non-sequitur | 1 |
| 391 | non-thienopyridine | 2 |
| 392 | noncentralized | 1 |
| 393 | noncollaborative | 1 |
| 394 | noncomparative | 157 |
| 395 | nonechocardiographer | 1 |
| 396 | noninferiority-designed | 1 |
| 397 | nonpelleted | 1 |
| 398 | nonphosphate | 1 |
| 399 | nonrandomized/partly | 1 |
| 400 | nonrestricted | 1 |
| 401 | north-to-south | 1 |
| 402 | nos-independent | 1 |
| 403 | novus | 3 |
| 404 | nurse-presented | 1 |
| 405 | older-specific | 1 |
| 406 | one-center | 6 |
| 407 | one-group | 28 |
| 408 | one-pill | 2 |
| 409 | orthopterans | 1 |
| 410 | p110δinhibitor | 1 |
| 411 | pan-world | 1 |
| 412 | parallel-designed | 17 |
| 413 | parallel-group-design | 1 |
| 414 | participation-oriented | 1 |
| 415 | patient-selective | 1 |
| 416 | patient/employee/employer/physician | 1 |
| 417 | peridischarge | 1 |
| 418 | pharyngolaryngobronchitis | 1 |
| 419 | phase-3 | 24 |
| 420 | phase-iii | 63 |
| 421 | phase-iiib | 2 |
| 422 | phosphatase-resistant | 1 |
| 423 | phosphatidylethnolamine | 1 |
| 424 | phosphatidylgylycerol | 1 |
| 425 | phosphatonin | 2 |
| 426 | photo-novel | 1 |
| 427 | phthalocyanine-derivative | 1 |
| 428 | physician-blind | 1 |
| 429 | physician-sponsored | 1 |
| 430 | picture-analyzer | 1 |
| 431 | pidgley | 1 |
| 432 | placed-controlled | 1 |
| 433 | platelet-stimulating | 1 |
| 434 | plum-sized | 1 |
| 435 | polymercaptosiloxane | 1 |
| 436 | pore-sized | 2 |
| 437 | post-2005 | 1 |
| 438 | post-only | 2 |
| 439 | post-test-only | 4 |
| 440 | pqdt | 1 |
| 441 | pre-post-design | 1 |
| 442 | pre-switched | 1 |
| 443 | preevaluation | 1 |
| 444 | preperitioneal | 1 |
| 445 | pride- | 1 |
| 446 | progenitor-like | 1 |
| 447 | proteome-scale | 1 |
| 448 | proto-typical | 1 |
| 449 | pseudo-residual | 1 |
| 450 | ptcl-restricted | 4 |
| 451 | pyranoquinolone | 1 |
| 452 | q318x | 1 |
| 453 | quasy-experimental | 1 |
| 454 | raisin- | 1 |
| 455 | random-coefficient-dependent | 1 |
| 456 | randomized-controlled-treatment | 1 |
| 457 | rectally-applied | 1 |
| 458 | reference-controlled | 5 |
| 459 | relapsed-aml2001/01 | 1 |
| 460 | replicate-use | 2 |
| 461 | researcher-initiated | 1 |
| 462 | resident-led | 2 |
| 463 | retrieval-phase | 1 |
| 464 | rickettsia-like | 1 |
| 465 | rotodynamic | 1 |
| 466 | round-bottomed | 1 |
| 467 | sam-riboswitch | 1 |
| 468 | sample-sized | 4 |
| 469 | science.finally | 1 |
| 470 | self-addressed | 4 |
| 471 | self-inducible | 1 |
| 472 | semi-isolated | 2 |
| 473 | semi-woody | 1 |
| 474 | semiblinded | 2 |
| 475 | semielevated | 1 |
| 476 | semirandomized | 6 |
| 477 | seroprophylaxis | 1 |
| 478 | seven-arm | 3 |
| 479 | seven-center | 3 |
| 480 | seven-site | 3 |
| 481 | seventeen-centre | 1 |
| 482 | sewer/gutter | 1 |
| 483 | sharp-pointed | 2 |
| 484 | shifts-randomized | 1 |
| 485 | sibling-split | 1 |
| 486 | simple-blinded | 1 |
| 487 | simple-in-design | 1 |
| 488 | simple-operating | 1 |
| 489 | single-antibiotic | 1 |
| 490 | single-arm | 314 |
| 491 | single-assessor | 2 |
| 492 | single-bind | 1 |
| 493 | single-center | 1,404 |
| 494 | single-centered | 10 |
| 495 | single-centre | 455 |
| 496 | single-centred | 11 |
| 497 | single-group | 40 |
| 498 | single-headed-toothbrush | 1 |
| 499 | single-institution | 93 |
| 500 | single-institutional | 13 |
| 501 | single-macronutrient | 1 |
| 502 | single-reviewer | 1 |
| 503 | single-surgeon | 11 |
| 504 | single-tiered | 1 |
| 505 | single-turn | 1 |
| 506 | single/multicenter | 1 |
| 507 | singlecenter | 3 |
| 508 | sittingposition | 1 |
| 509 | six-armed | 2 |
| 510 | six-center | 6 |
| 511 | six-sites | 1 |
| 512 | six-week-treatment | 1 |
| 513 | soap-opera-themed | 1 |
| 514 | solemn | 1 |
| 515 | sound-proofed | 1 |
| 516 | soy-protein-isolate | 1 |
| 517 | sp6likevirus | 1 |
| 518 | specialist-administered | 1 |
| 519 | sperm-interacting | 1 |
| 520 | staged-based | 1 |
| 521 | staggered-entry | 2 |
| 522 | statine | 2 |
| 523 | stepped-wedge | 33 |
| 524 | strain-unspecific | 1 |
| 525 | strawberry- | 1 |
| 526 | study-case-control | 1 |
| 527 | subcutaneous-mucosa | 1 |
| 528 | sulphonlyurea | 1 |
| 529 | superblade | 1 |
| 530 | surgeon-blinded | 2 |
| 531 | surgeon-masked | 1 |
| 532 | task-battery | 1 |
| 533 | te23 | 2 |
| 534 | teammate | 1 |
| 535 | temporally-correct | 1 |
| 536 | temporary-type | 1 |
| 537 | ten-variable | 1 |
| 538 | tensipresser | 1 |
| 539 | test-age-equivalent | 1 |
| 540 | test-chart | 1 |
| 541 | tetrahexose | 1 |
| 542 | tetrahydrobenzocyclononenone | 1 |
| 543 | th1-pathway | 1 |
| 544 | then-standard | 1 |
| 545 | theoretically-defensible | 1 |
| 546 | theoreticallydriven | 1 |
| 547 | three-arm | 252 |
| 548 | three-armed | 83 |
| 549 | three-attack | 1 |
| 550 | three-centre | 7 |
| 551 | three-group | 60 |
| 552 | three-plus-three | 1 |
| 553 | thrilling | 3 |
| 554 | time-clustered | 1 |
| 555 | time-sequence | 3 |
| 556 | titration-protocol | 1 |
| 557 | tnfr1/jnk1/2 | 1 |
| 558 | toluene-resistant | 1 |
| 559 | trackball | 2 |
| 560 | training-independent | 1 |
| 561 | trans-national | 1 |
| 562 | treatment-derived | 1 |
| 563 | trial.obviously | 1 |
| 564 | triazolobenzodiazepine | 2 |
| 565 | trihexose | 2 |
| 566 | triple-injection | 1 |
| 567 | triventricular | 2 |
| 568 | trpv1-antagonist | 1 |
| 569 | tunnel-ventilated | 1 |
| 570 | twenty-year | 4 |
| 571 | twin-center | 1 |
| 572 | two-arm | 424 |
| 573 | two-armed | 125 |
| 574 | two-arms | 2 |
| 575 | two-center | 65 |
| 576 | two-centre | 46 |
| 577 | two-centred | 1 |
| 578 | two-chambered | 1 |
| 579 | two-cohort | 9 |
| 580 | two-county | 23 |
| 581 | two-diet | 1 |
| 582 | two-group | 208 |
| 583 | two-pole | 1 |
| 584 | two-treatment-arms | 1 |
| 585 | uichronic | 1 |
| 586 | ultrasonographic-screening | 1 |
| 587 | undoable | 1 |
| 588 | unicenter | 14 |
| 589 | universal-coverage | 1 |
| 590 | university-affiliate | 1 |
| 591 | user-driven | 1 |
| 592 | vaccine-probe-study | 1 |
| 593 | varicocoele | 1 |
| 594 | verapamil-sr/trandolapril | 2 |
| 595 | verapamil-trandolapril | 6 |
| 596 | viking | 1 |
| 597 | visually-identical | 1 |
| 598 | vulnery | 1 |
| 599 | wearisome | 1 |
| 600 | well-corticated | 1 |
| 601 | well-randomized | 1 |
| 602 | westerner | 1 |
| 603 | westlaw | 1 |
| 604 | wide-reach | 1 |
| 605 | widespread-growing | 1 |
| 606 | windbreak | 1 |
| 607 | within-nested | 1 |
| 608 | within-organizations | 1 |
| 609 | within-subject-design | 1 |
| 610 | woman.usually | 1 |
| 611 | yoghurt- | 1 |
| 612 | zinc-metalloendopeptidase | 1 |
| 613 | ø5-mm | 1 |
| 614 | κ³-manner | 1 |
| 615 | μ3-hydride | 1 |
| 616 | €590±43 | 1 |
| 617 | ≤68-week | 1 |
| 1 | pride- | 1 |
| 2 | g-csf- | 1 |
| 3 | raisin- | 1 |
| 4 | 3-nitro- | 1 |
| 5 | yoghurt- | 1 |
| 6 | strawberry- | 1 |
| 7 | 2-benzyloxy- | 1 |
| 8 | cyp2c9/10 | 2 |
| 9 | 15,760 | 1 |
| 10 | achieve-1 | 2 |
| 11 | relapsed-aml2001/01 | 1 |
| 12 | lym-3001 | 1 |
| 13 | 6,711 | 1 |
| 14 | mir-371 | 1 |
| 15 | tnfr1/jnk1/2 | 1 |
| 16 | association-9802 | 1 |
| 17 | phase-3 | 24 |
| 18 | lipex-403 | 1 |
| 19 | 104:12518-12523 | 1 |
| 20 | te23 | 2 |
| 21 | €590±43 | 1 |
| 22 | d1-d3 | 4 |
| 23 | hr=1.14 | 1 |
| 24 | cao/aro/aio-94 | 8 |
| 25 | post-2005 | 1 |
| 26 | 3558 | 2 |
| 27 | crca | 1 |
| 28 | barriada | 1 |
| 29 | 42.5-kda | 1 |
| 30 | sulphonlyurea | 1 |
| 31 | dysnatraemia | 1 |
| 32 | c.584dela | 1 |
| 33 | 60-ma | 1 |
| 34 | 0.75-ma | 1 |
| 35 | 0.9-ma | 1 |
| 36 | 36-antenna | 1 |
| 37 | subcutaneous-mucosa | 1 |
| 38 | balaclava | 1 |
| 39 | 82b | 2 |
| 40 | phase-iiib | 2 |
| 41 | corymb | 1 |
| 42 | cis-c | 1 |
| 43 | 82c | 2 |
| 44 | kopac | 2 |
| 45 | hispanic-specific | 1 |
| 46 | older-specific | 1 |
| 47 | flower-specific | 1 |
| 48 | strain-unspecific | 1 |
| 49 | rotodynamic | 1 |
| 50 | multiclinic | 13 |
| 51 | uichronic | 1 |
| 52 | non-isotropic | 1 |
| 53 | multi-centric | 20 |
| 54 | mono-centric | 3 |
| 55 | multicentric | 297 |
| 56 | monocentric | 87 |
| 57 | single-antibiotic | 1 |
| 58 | 383-d | 1 |
| 59 | 300-bed | 5 |
| 60 | 1,300-bed | 1 |
| 61 | 390-bed | 1 |
| 62 | 31-bed | 1 |
| 63 | haloperidol-referenced | 1 |
| 64 | chloride-reduced | 1 |
| 65 | calorie-reduced | 1 |
| 66 | gold-shaded | 1 |
| 67 | simple-blinded | 1 |
| 68 | surgeon-blinded | 2 |
| 69 | grader-blinded | 3 |
| 70 | semiblinded | 2 |
| 71 | nida-funded | 1 |
| 72 | dhhs-funded | 1 |
| 73 | sound-proofed | 1 |
| 74 | pre-switched | 1 |
| 75 | co-published | 2 |
| 76 | rectally-applied | 1 |
| 77 | surgeon-masked | 1 |
| 78 | resident-led | 2 |
| 79 | copper-sulfate-filled | 1 |
| 80 | placed-controlled | 1 |
| 81 | carotenoid-controlled | 1 |
| 82 | reference-controlled | 5 |
| 83 | soap-opera-themed | 1 |
| 84 | round-bottomed | 1 |
| 85 | 2-armed | 16 |
| 86 | 3-armed | 22 |
| 87 | three-armed | 83 |
| 88 | two-armed | 125 |
| 89 | four-armed | 10 |
| 90 | six-armed | 2 |
| 91 | factorial-designed | 2 |
| 92 | parallel-designed | 17 |
| 93 | identically-designed | 2 |
| 94 | noninferiority-designed | 1 |
| 95 | community-planned | 2 |
| 96 | county-owned | 1 |
| 97 | two-chambered | 1 |
| 98 | large-numbered | 1 |
| 99 | single-tiered | 1 |
| 100 | single-centered | 10 |
| 101 | multi-centered | 45 |
| 102 | behaviorally-centered | 1 |
| 103 | multicentered | 98 |
| 104 | specialist-administered | 1 |
| 105 | time-clustered | 1 |
| 106 | firefighter-delivered | 1 |
| 107 | low-powered | 4 |
| 108 | fully-powered | 6 |
| 109 | locally-tailored | 2 |
| 110 | physician-sponsored | 1 |
| 111 | single-centred | 11 |
| 112 | multi-centred | 36 |
| 113 | two-centred | 1 |
| 114 | multicentred | 26 |
| 115 | staged-based | 1 |
| 116 | lard-based | 1 |
| 117 | hawaiian-based | 1 |
| 118 | cpo-based | 1 |
| 119 | gp-based | 4 |
| 120 | district-based | 1 |
| 121 | conceptually-based | 1 |
| 122 | dictionary-based | 1 |
| 123 | 3-phased | 1 |
| 124 | double-phased | 1 |
| 125 | multiphased | 1 |
| 126 | group-randomised | 4 |
| 127 | community-randomised | 10 |
| 128 | non-detubularised | 1 |
| 129 | self-addressed | 4 |
| 130 | male-focused | 1 |
| 131 | well-corticated | 1 |
| 132 | magnesium-mediated | 1 |
| 133 | researcher-initiated | 1 |
| 134 | cd4-related | 1 |
| 135 | m-inflated | 1 |
| 136 | tunnel-ventilated | 1 |
| 137 | semi-isolated | 2 |
| 138 | defucosylated | 1 |
| 139 | cdc-designated | 1 |
| 140 | carbohydrate-coated | 1 |
| 141 | community-integrated | 1 |
| 142 | semielevated | 1 |
| 143 | chemically-activated | 1 |
| 144 | dental-directed | 1 |
| 145 | non-calorie-restricted | 1 |
| 146 | ptcl-restricted | 4 |
| 147 | nonrestricted | 1 |
| 148 | nonpelleted | 1 |
| 149 | participation-oriented | 1 |
| 150 | k-space-segmented | 1 |
| 151 | nurse-presented | 1 |
| 152 | sharp-pointed | 2 |
| 153 | lighthearted | 1 |
| 154 | within-nested | 1 |
| 155 | cohort-nested | 2 |
| 156 | llama-derived | 1 |
| 157 | non-plasma-derived | 1 |
| 158 | bee-derived | 1 |
| 159 | treatment-derived | 1 |
| 160 | 510k-approved | 1 |
| 161 | matrixed | 1 |
| 162 | noncentralized | 1 |
| 163 | dose-block-randomized | 1 |
| 164 | well-randomized | 1 |
| 165 | multicenter-randomized | 1 |
| 166 | shifts-randomized | 1 |
| 167 | community-randomized | 23 |
| 168 | semirandomized | 6 |
| 169 | sample-sized | 4 |
| 170 | pore-sized | 2 |
| 171 | plum-sized | 1 |
| 172 | half-solid | 1 |
| 173 | pan-world | 1 |
| 174 | low-resource-demand | 1 |
| 175 | single-bind | 1 |
| 176 | non-double-blind | 2 |
| 177 | multiple-blind | 1 |
| 178 | physician-blind | 1 |
| 179 | non-blind | 30 |
| 180 | double/blind | 1 |
| 181 | 29-month-period | 1 |
| 182 | 4-year-period | 1 |
| 183 | growing-rod | 1 |
| 184 | then-standard | 1 |
| 185 | nephrostomy-tube | 1 |
| 186 | multipractice | 6 |
| 187 | time-sequence | 3 |
| 188 | multiprovince | 1 |
| 189 | superblade | 1 |
| 190 | dimethylbiguanide | 1 |
| 191 | μ3-hydride | 1 |
| 192 | c-galloylglycoside | 1 |
| 193 | ketoaldehyde | 1 |
| 194 | 2-oxoaldehyde | 1 |
| 195 | c-free | 1 |
| 196 | three-plus-three | 1 |
| 197 | net-cage | 1 |
| 198 | universal-coverage | 1 |
| 199 | stepped-wedge | 33 |
| 200 | peridischarge | 1 |
| 201 | large-gauge | 1 |
| 202 | non-rattlesnake | 1 |
| 203 | he65-like | 1 |
| 204 | rickettsia-like | 1 |
| 205 | dutpase-like | 1 |
| 206 | defensive-like | 1 |
| 207 | progenitor-like | 1 |
| 208 | proteome-scale | 1 |
| 209 | non-detachable | 1 |
| 210 | ten-variable | 1 |
| 211 | undoable | 1 |
| 212 | self-inducible | 1 |
| 213 | theoretically-defensible | 1 |
| 214 | hyperflexible | 1 |
| 215 | light-porous-particle | 1 |
| 216 | varicocoele | 1 |
| 217 | dinucleophile | 1 |
| 218 | dielectrophile | 1 |
| 219 | two-pole | 1 |
| 220 | dichotomousoutcome | 1 |
| 221 | wearisome | 1 |
| 222 | polymercaptosiloxane | 1 |
| 223 | bi-gene | 1 |
| 224 | cyclopentyltriazolopyrimidine | 1 |
| 225 | diphenylbutylpiperidine | 1 |
| 226 | non-thienopyridine | 2 |
| 227 | copa-airline | 1 |
| 228 | phosphatidylethnolamine | 1 |
| 229 | non-amphetamine | 1 |
| 230 | 1,5-benzodiazepine | 1 |
| 231 | triazolobenzodiazepine | 2 |
| 232 | statine | 2 |
| 233 | 2-aminoazine | 1 |
| 234 | difference.one | 1 |
| 235 | fluoro-chinolone | 1 |
| 236 | pyranoquinolone | 1 |
| 237 | tetrahydrobenzocyclononenone | 1 |
| 238 | 4'-hydroxy-3-methoxyflavone | 1 |
| 239 | limited-scope | 2 |
| 240 | meatourethroscope | 1 |
| 241 | helmet-type | 1 |
| 242 | temporary-type | 1 |
| 243 | ,were | 1 |
| 244 | 2-centre | 3 |
| 245 | three-centre | 7 |
| 246 | double-centre | 4 |
| 247 | single-centre | 455 |
| 248 | five-centre | 1 |
| 249 | multi-centre | 746 |
| 250 | seventeen-centre | 1 |
| 251 | mono-centre | 4 |
| 252 | two-centre | 46 |
| 253 | multicentre | 3,200 |
| 254 | medium-temperature | 1 |
| 255 | 75-base | 1 |
| 256 | zinc-metalloendopeptidase | 1 |
| 257 | first-in-disease | 1 |
| 258 | retrieval-phase | 1 |
| 259 | low-phase | 1 |
| 260 | metallo-ß-lactamase | 1 |
| 261 | booster-dose | 1 |
| 262 | tetrahexose | 1 |
| 263 | trihexose | 2 |
| 264 | hf-nurse | 1 |
| 265 | replicate-use | 2 |
| 266 | nonphosphate | 1 |
| 267 | university-affiliate | 1 |
| 268 | soy-protein-isolate | 1 |
| 269 | teammate | 1 |
| 270 | high-complex-carbohydrate | 1 |
| 271 | five-site | 4 |
| 272 | multi-site | 267 |
| 273 | seven-site | 3 |
| 274 | four-site | 12 |
| 275 | multisite | 553 |
| 276 | 34-residue | 1 |
| 277 | coping-technique | 1 |
| 278 | 4-wave | 1 |
| 279 | cbt-naive | 1 |
| 280 | melibiose-negative | 1 |
| 281 | lactose-negative | 1 |
| 282 | noncomparative | 157 |
| 283 | multicenter-cooperative | 1 |
| 284 | noncollaborative | 1 |
| 285 | naphthalene-derivative | 1 |
| 286 | phthalocyanine-derivative | 1 |
| 287 | bio-inactive | 1 |
| 288 | patient-selective | 1 |
| 289 | heparin-sensitive | 1 |
| 290 | mek-inhibitor-sensitive | 1 |
| 291 | health-literacy-sensitive | 1 |
| 292 | hyper-reflexive | 1 |
| 293 | fiancée | 1 |
| 294 | counterproof | 1 |
| 295 | non-ivf | 2 |
| 296 | 1551-g | 1 |
| 297 | dissonance-enhancing | 1 |
| 298 | dose/duration-ranging | 1 |
| 299 | deep-reaching | 1 |
| 300 | dose-searching | 1 |
| 301 | light-pecking | 1 |
| 302 | viking | 1 |
| 303 | clinic-modelling | 1 |
| 304 | thrilling | 3 |
| 305 | non-protein-forming | 1 |
| 306 | ultrasonographic-screening | 1 |
| 307 | fast-learning | 1 |
| 308 | fast-mapping | 1 |
| 309 | platelet-stimulating | 1 |
| 310 | simple-operating | 1 |
| 311 | later-acting | 1 |
| 312 | sperm-interacting | 1 |
| 313 | widespread-growing | 1 |
| 314 | 95,299-bp-long | 1 |
| 315 | wide-reach | 1 |
| 316 | flavone-rich | 1 |
| 317 | mannose-rich | 1 |
| 318 | hunch | 1 |
| 319 | forsch | 1 |
| 320 | sam-riboswitch | 1 |
| 321 | single-headed-toothbrush | 1 |
| 322 | north-to-south | 1 |
| 323 | caregiver-youth | 1 |
| 324 | clear-ivh | 1 |
| 325 | phase-iii | 63 |
| 326 | 50j | 1 |
| 327 | windbreak | 1 |
| 328 | three-attack | 1 |
| 329 | intra-lock | 1 |
| 330 | hummock | 1 |
| 331 | 50-week | 7 |
| 332 | 51-week | 3 |
| 333 | 6-12-week | 1 |
| 334 | 16-24-week | 1 |
| 335 | 10-16-week | 1 |
| 336 | ≤68-week | 1 |
| 337 | bookmark | 1 |
| 338 | bayesian-framework | 1 |
| 339 | double-mask | 2 |
| 340 | cilinical | 1 |
| 341 | proto-typical | 1 |
| 342 | visually-identical | 1 |
| 343 | descriptive-analytical | 2 |
| 344 | preperitioneal | 1 |
| 345 | 9-trial | 1 |
| 346 | multi-centre-randomised-trial | 1 |
| 347 | four-trial | 1 |
| 348 | multi-national | 32 |
| 349 | trans-national | 1 |
| 350 | binational | 7 |
| 351 | multinational | 700 |
| 352 | non-interventional | 105 |
| 353 | single-institutional | 13 |
| 354 | multi-institutional | 189 |
| 355 | multiinstitutional | 18 |
| 356 | multi-behavioral | 1 |
| 357 | multihospital | 5 |
| 358 | quasy-experimental | 1 |
| 359 | pseudo-residual | 1 |
| 360 | multi-interval | 1 |
| 361 | medication-withdrawal | 1 |
| 362 | logistic-regression-model | 1 |
| 363 | haemocoel | 1 |
| 364 | daily-level | 2 |
| 365 | photo-novel | 1 |
| 366 | codicil | 1 |
| 367 | verapamil-trandolapril | 6 |
| 368 | verapamil-sr/trandolapril | 2 |
| 369 | trackball | 2 |
| 370 | one-pill | 2 |
| 371 | 5.0ml | 1 |
| 372 | titration-protocol | 1 |
| 373 | febuxostat/allopurinol | 1 |
| 374 | phosphatidylgylycerol | 1 |
| 375 | myopia-control | 1 |
| 376 | double-control | 1 |
| 377 | study-case-control | 1 |
| 378 | high-sense-of-control | 1 |
| 379 | maasol | 1 |
| 380 | babygirl | 1 |
| 381 | 1.7-cm | 1 |
| 382 | 61-item | 1 |
| 383 | 76-item | 1 |
| 384 | ø5-mm | 1 |
| 385 | 2-arm | 124 |
| 386 | 3-arm | 108 |
| 387 | 4-arm | 37 |
| 388 | 5-arm | 4 |
| 389 | 6-arm | 1 |
| 390 | three-arm | 252 |
| 391 | single-arm | 314 |
| 392 | five-arm | 12 |
| 393 | dual-arm | 5 |
| 394 | 3-parallel-arm | 1 |
| 395 | four-parallel-arm | 1 |
| 396 | seven-arm | 3 |
| 397 | two-arm | 424 |
| 398 | four-arm | 67 |
| 399 | hilbert-transform | 1 |
| 400 | certican | 3 |
| 401 | patient/employee/employer/physician | 1 |
| 402 | european-australian | 4 |
| 403 | gondwanatherian | 1 |
| 404 | danish-austrian | 1 |
| 405 | chore/burden | 1 |
| 406 | user-driven | 1 |
| 407 | theoreticallydriven | 1 |
| 408 | simple-in-design | 1 |
| 409 | parallel-group-design | 1 |
| 410 | within-subject-design | 1 |
| 411 | pre-post-design | 1 |
| 412 | australia.design | 1 |
| 413 | cognin | 1 |
| 414 | phosphatonin | 2 |
| 415 | gauguin | 1 |
| 416 | solemn | 1 |
| 417 | 2-weeks-on | 1 |
| 418 | multi-replicon | 1 |
| 419 | single-surgeon | 11 |
| 420 | multisurgeon | 7 |
| 421 | denunciation | 1 |
| 422 | high-risk-population | 1 |
| 423 | flexstation | 1 |
| 424 | preevaluation | 1 |
| 425 | triple-injection | 1 |
| 426 | sittingposition | 1 |
| 427 | high-retention | 1 |
| 428 | multi-intention | 1 |
| 429 | 17-question | 1 |
| 430 | cycling-to-exhaustion | 1 |
| 431 | 25-institution | 1 |
| 432 | single-institution | 93 |
| 433 | multi-institution | 9 |
| 434 | mirtron | 1 |
| 435 | 4-lesson | 1 |
| 436 | single-turn | 1 |
| 437 | botiquín | 1 |
| 438 | cao-aro | 1 |
| 439 | geparquattro | 4 |
| 440 | geparquinto | 7 |
| 441 | 15-lap | 1 |
| 442 | 2-group | 69 |
| 443 | 3-group | 28 |
| 444 | three-group | 60 |
| 445 | single-group | 40 |
| 446 | one-group | 28 |
| 447 | comparative-group | 1 |
| 448 | two-group | 208 |
| 449 | dolderbar | 1 |
| 450 | 4.25-year | 1 |
| 451 | twenty-year | 4 |
| 452 | triventricular | 2 |
| 453 | nonechocardiographer | 1 |
| 454 | non-betablocker | 1 |
| 455 | κ³-manner | 1 |
| 456 | westerner | 1 |
| 457 | tensipresser | 1 |
| 458 | 3-center | 5 |
| 459 | 4-center | 8 |
| 460 | 7-center | 1 |
| 461 | 9-center | 2 |
| 462 | 19-center | 1 |
| 463 | 39-center | 1 |
| 464 | single-center | 1,404 |
| 465 | multiple-center | 13 |
| 466 | nine-center | 1 |
| 467 | one-center | 6 |
| 468 | five-center | 6 |
| 469 | multi-center | 761 |
| 470 | dual-center | 9 |
| 471 | seven-center | 3 |
| 472 | twin-center | 1 |
| 473 | mono-center | 6 |
| 474 | two-center | 65 |
| 475 | four-center | 7 |
| 476 | six-center | 6 |
| 477 | singlecenter | 3 |
| 478 | unicenter | 14 |
| 479 | multicenter | 9,074 |
| 480 | single/multicenter | 1 |
| 481 | monocenter | 21 |
| 482 | fourcenter | 1 |
| 483 | gamma-counter | 1 |
| 484 | c-counter | 1 |
| 485 | household-cluster | 2 |
| 486 | sewer/gutter | 1 |
| 487 | single-reviewer | 1 |
| 488 | co-sensitizer | 1 |
| 489 | picture-analyzer | 1 |
| 490 | 40-fr | 2 |
| 491 | single-assessor | 2 |
| 492 | cofactor-based-inhibitor | 1 |
| 493 | cyclooxygenase-inhibitor | 1 |
| 494 | hmg-coa-reductase-inhibitor | 1 |
| 495 | p110δinhibitor | 1 |
| 496 | non-sequitur | 1 |
| 497 | 3.4-yr | 1 |
| 498 | six-sites | 1 |
| 499 | descriptive-analysis | 1 |
| 500 | pharyngolaryngobronchitis | 1 |
| 501 | seroprophylaxis | 1 |
| 502 | beggarticks | 2 |
| 503 | goldilocks | 1 |
| 504 | two-arms | 2 |
| 505 | two-treatment-arms | 1 |
| 506 | orthopterans | 1 |
| 507 | within-organizations | 1 |
| 508 | hodos | 1 |
| 509 | multicenters | 4 |
| 510 | 11-nprs | 1 |
| 511 | 12-class | 1 |
| 512 | comparative-effectiveness | 14 |
| 513 | multicampus | 2 |
| 514 | sp6likevirus | 1 |
| 515 | novus | 3 |
| 516 | five-contact | 1 |
| 517 | five-subject | 1 |
| 518 | multiple-project | 2 |
| 519 | temporally-correct | 1 |
| 520 | less-distinct | 1 |
| 521 | cvrct | 4 |
| 522 | pqdt | 1 |
| 523 | mhf-diet | 2 |
| 524 | two-diet | 1 |
| 525 | cormet | 1 |
| 526 | 42-night | 1 |
| 527 | multi-night | 1 |
| 528 | no-profit | 3 |
| 529 | margit | 1 |
| 530 | sibling-split | 1 |
| 531 | magrit | 2 |
| 532 | clarificant | 1 |
| 533 | 3300-participant | 1 |
| 534 | 7,447-participant | 1 |
| 535 | 48-participant | 2 |
| 536 | toluene-resistant | 1 |
| 537 | phosphatase-resistant | 1 |
| 538 | cicatrizant | 1 |
| 539 | random-coefficient-dependent | 1 |
| 540 | glutathione-independent | 1 |
| 541 | training-independent | 1 |
| 542 | nos-independent | 1 |
| 543 | disulfide-deficient | 1 |
| 544 | calorie-sufficient | 2 |
| 545 | single-macronutrient | 1 |
| 546 | 2000-patient | 1 |
| 547 | 3000-patient | 1 |
| 548 | 4000-patient | 1 |
| 549 | 7000-patient | 1 |
| 550 | 1,300-patient | 2 |
| 551 | 600-patient | 2 |
| 552 | 700-patient | 1 |
| 553 | 2,010-patient | 1 |
| 554 | 2010-patient | 3 |
| 555 | 90-patient | 1 |
| 556 | 31-patient | 1 |
| 557 | 79-patient | 1 |
| 558 | test-age-equivalent | 1 |
| 559 | randomized-controlled-treatment | 1 |
| 560 | six-week-treatment | 1 |
| 561 | high-wnt | 1 |
| 562 | test-chart | 1 |
| 563 | 2-part | 39 |
| 564 | two-cohort | 9 |
| 565 | multicohort | 3 |
| 566 | longport | 1 |
| 567 | gene-of-interest | 1 |
| 568 | geneticist/oncologist | 1 |
| 569 | trpv1-antagonist | 1 |
| 570 | d2/d3-antagonist | 1 |
| 571 | neurolinguist | 1 |
| 572 | mmc/5-fu | 1 |
| 573 | arteries-iv | 1 |
| 574 | 5-w | 1 |
| 575 | westlaw | 1 |
| 576 | jew | 1 |
| 577 | q318x | 1 |
| 578 | no-mix | 1 |
| 579 | equinox | 3 |
| 580 | 78-day | 1 |
| 581 | head-mounted-display | 1 |
| 582 | midewanniquay | 1 |
| 583 | th1-pathway | 1 |
| 584 | busybody | 1 |
| 585 | semi-woody | 1 |
| 586 | vaccine-probe-study | 1 |
| 587 | pidgley | 1 |
| 588 | boggy | 1 |
| 589 | microtechnology | 2 |
| 590 | monarchy | 1 |
| 591 | chondrodystrophy | 1 |
| 592 | month/bimonthly | 1 |
| 593 | science.finally | 1 |
| 594 | woman.usually | 1 |
| 595 | post-test-only | 4 |
| 596 | post-only | 2 |
| 597 | trial.obviously | 1 |
| 598 | nonrandomized/partly | 1 |
| 599 | vulnery | 1 |
| 600 | task-battery | 1 |
| 601 | microbrewery | 1 |
| 602 | framework/theory | 1 |
| 603 | hypermigratory | 1 |
| 604 | cut-and-carry | 1 |
| 605 | staggered-entry | 2 |
| 606 | multi-country | 31 |
| 607 | multicountry | 20 |
| 608 | monomodality | 1 |
| 609 | lesser-quality | 5 |
| 610 | 20-community | 2 |
| 611 | 22-community | 1 |
| 612 | low-impulsivity | 1 |
| 613 | two-county | 23 |
| 614 | ectaz | 2 |
| 615 | 915-mhz | 1 |
| 616 | breathtron® | 1 |
| 617 | galactosyl-α | 1 |